EMA
approval
· 2012-10-19
European Medicines Agency recommends approval of first radiopharmaceutical for PET imaging of β-amyloid neuritic plaque density
Summary
EMA recommends approval of the first radiopharmaceutical for PET imaging of beta-amyloid neuritic plaque density, enabling visualization of amyloid plaques in t…
Upgrade for the full analysis, importance score, and drug timeline.